10 Things Worth Pay...
Health Care: Drugs
Allergan Inc. (AGN: NYSE)
$88.58 0.49 | 0.56%
06/04/12 - 04:02 PM ET
Company Profile
| Price and Volume | |
|---|---|
| Recent Price | 88.09 |
| 52 Week High | 97.09 |
| 52 Week Low | 69.40 |
| Avg. Daily Vol. (Mil) | 1.58 |
| Beta (3 year) | 0.70 |
| Share Related Items | |
| Mkt Cap (Mil) | 26,734.63 |
| Shares Out (Mil) | 303.49 |
| Float (Mil) | 304.06 |
| Dividend Information | |
| Yield % | 0.20 |
| Annual Dividend | 0.20 |
| Payout Ratio | 6.00 |
| Financial Strength | |
| Quick Ratio | 3.60 |
| Current Ratio | 4.40 |
| LT Debt/ Equity | 0.28 |
| Total Debt / Equity | 0.29 |
| Valuation Ratios | |
| Price Earnings | 27.20 |
| Price/Sales | 4.83 |
| Price/Book | 4.90 |
| Price/Cash Flow | 21.20 |
| Per Share Data | |
| Earnings | 3.24 |
| Sales | 18.25 |
| Book Value | 17.99 |
| Cash Flow | 4.15 |
| Business Summary | |
|---|---|
| Allergan, Inc. is a multi-specialty health care company focused on developing and commercializing innovative pharmaceuticals, biologics and medical devices that enable people to live life to its greatest potential. | |
| General Information | |
| 2525 Dupont Drive
Irvine, CA 92612 |
|
| www.allergan.com | |
| Industry : Drugs | |
| Sector: Health Care | |
| Employees: 10000 | |
| CEO: David E.I. Pyott | |
| Short Interest | |
| Current Month (Mil) | 5.03 |
| Previous Month (Mil) | 3.93 |
| Short Interest Ratio (Days) | 3.10 |
| Management Effectiveness | |
| Return on Equity | 18.40 |
| Return on Assets | 11.60 |
| Return on Investments | 14.40 |
| Profitability | |
| Gross Margin | 88.60 |
| EBIT Margin | 26.60 |
| Profit Margin | 18.20 |
Portfolios with AGN
- Portfolio NameUser Type
- UserOil/Gas Feb 2012
- Contributor7 Stocks Set To Rise at Lea...
- UserCLUBCAR47 Portfolio 1
- UserLes's Picks
- ProBridger Management
- ContributorTop 20 Stocks With Large Se...
- ContributorRocket Stocks for the Week ...
- Contributor10 Pharmaceutical Stocks Wi...
- ContributorCramer's Openings in Health...
- ContributorCramer's Vice and Vanity St...
Latest AGN Headlines from TheStreet
- Allergan Stock To Go Ex-dividend Tomorrow (AGN) 05.21.12 | 09:05 am
- Ex-Dividend Stocks: Thomson Reuters, Infosys 05.21.12 | 05:05 am
- Cramer's 'Mad Money' Recap: 7 Stocks to Scoop Up When On Sale 05.09.12 | 08:05 pm
- Allergan Inc. (AGN): Today's Featured Drugs Winner 05.03.12 | 05:05 pm
- Allergan Management Discusses Q1 2012 Results - Earnings Call Transcript 05.02.12 | 04:05 pm
- 3 Stocks I Saw on TV, May 2
05.02.12 | 08:05 am - The Week Ahead: Jobs Data; Earnings from MasterCard, Visa, Whole Foods 04.29.12 | 06:04 pm
- Allergan Stock Hits New 52-Week High (AGN) 04.26.12 | 01:04 pm
- 3 Stocks I Saw on TV, April 13 04.13.12 | 08:04 am
- Cramer's 'Mad Money' Recap: Love and Hip Stocks (Final) 04.12.12 | 06:04 pm
Press Releases for AGN
- Allergan Reports First Quarter 2012 Operating Results - Business Wire 05.02.12 | 09:05 am
- BOTOX® Cosmetic (onabotulinumtoxinA) Celebrates 10-Year Anniversary Of U.S. Food And Drug Administration Approval - Business Wire 04.13.12 | 09:04 am
- Allergan Announces Quarterly Conference Call - Business Wire 04.06.12 | 01:04 pm
- Allergan Announces Positive Top-Line Results From Phase III BOTOX® Overactive Bladder Program - Business Wire 03.28.12 | 09:03 am
- U.S. Federal Court Finds In Favor Of Allergan, Inc. And Issues Permanent Injunction Against Merz Pharmaceuticals And Merz Aesthetics - Business Wire 03.12.12 | 09:03 am
- Allergan Announces Research & Development Technology Review - Business Wire 02.15.12 | 04:02 pm
- Allergan Reports Fourth Quarter 2011 Operating Results - Business Wire 02.02.12 | 09:02 am
- Allergan Announces Quarterly Conference Call - Business Wire 01.06.12 | 06:01 pm
- Actress Christina Hendricks Urges Women To Join Her In The Final Weeks Of The LATISSE® Wishes Challenge To Increase Money Raised For The Make-A-Wish Foundation® From $390,000 To Campaign Goal Of $500,000 - PR Newswire 11.09.11 | 08:11 am
- Allergan Reports Third Quarter 2011 Operating Results - Business Wire 10.26.11 | 09:10 am
Partner Headlines for AGN
- Time To Take Another Look At The Biotechnology Sector - Seeking Alpha 04.09.12 | 09:04 am
- Cracker Barrel and Other Stocks Insiders Are Buying - Benzinga 04.06.12 | 06:04 am
- Court Deals Blow to Botox Competitor - Analyst Blog - Zacks 03.16.12 | 05:03 pm
- MAP Pharma: Making Money From Migraines - Seeking Alpha 03.11.12 | 09:03 am
- Cramer's Mad Money - 15 Things To Watch This Week (1/27/12) - Seeking Alpha 01.29.12 | 07:01 am
- 6 Drug Companies Favored By Hedge Funds - Seeking Alpha 01.05.12 | 09:01 am
- ETF Showdown: Fun With Pharma - Benzinga 12.30.11 | 04:12 pm
- A Look At Atalanta Sosnoff Capital's Top Buys - Seeking Alpha 11.17.11 | 08:11 am
- Medicis Misses Zacks Consensus - Analyst Blog - Zacks 11.11.11 | 10:11 am
- A Look at The New DRGS ETN - Benzinga 10.31.11 | 01:10 pm
